Heim Global Consulting LLC— inspiring health transformation in medical affairs, public affairs, and operations in the pharmaceutical and medical device industries

Healthcare companies face several challenges today: changes in customer behavior, regulatory demands, and market dynamics. Healthcare consultants work with healthcare companies to innovate, drive better value for patients, and reduce the complexity and cost of operating systems.

Healthcare consulting companies provide health organizations with professional guidance spanning a wide range of services, including manufactured goods, mobile devices, information systems, retail, and more.

Heim Global Consulting offers some of the most innovative consulting services in the Pharmaceutical and medical devices industries. They are results-oriented Global Strategic Consultants who inspire health transformation in medical affairs, public affairs, and operations in the pharmaceutical and medical device industries. As scientists, strategists, advocates, and business executives, Heim Global Consulting thrives on sharing its experience and knowledge to help your business succeed while accelerating your product delivery.

The following excerpts were taken from a conversation with Meg Heim, Founder, and President of Heim Global Consulting LLC

Q. Can you tell us a little about Heim Global Consulting? Why was the company set up and its raison d’etre?

After many years in the Pharmaceutical and Medical Device industry as executives, launching products and devices globally, we decided to alter our direction. Now, we share our passion for helping others. Pharma, Biotech, VC, Scientific Societies, and Patient Advocacy groups all have a place in bringing innovative products to market and securing access. Heim Global Consulting benefits from a strong group of experienced pharmaceutical executives and scientific consultants who provide senior-level strategic and operational support, with knowledge across all facets of the business and lifecycle.

Q. Why did you find it necessary to start a consulting firm for the medical and pharmaceutical sectors?

This is an incredible time of growth. Launches and R & D were delayed due to the pandemic. Companies are trying to regain the lost time with a hybrid return to work, life, and a general change in atmosphere. Add that to a workforce shortage; boutique high-level consulting is a needed product and part of the plan to accelerate to market.

Q. What services does Heim Global Consulting provide to its customers?

We’re a boutique firm of results-oriented Global Strategic Consultants who inspire health transformation in Medical Affairs, Public Affairs, and Operations. As Strategists, Scientists, Advocates, and Business Executives, we thrive on sharing our experience and knowledge to help make businesses successful while accelerating product delivery. Our accelerated process builds and empowers life science teams while outfitting them with the tools they need to succeed. We can support growth, accelerate plans, and put teams on a solid track to success!

Q. Heim Global Consulting’s mantra is: analyze, identify, advise, execute. Can you give examples of how the company has implemented its mantra?

This is our mantra as well as our business model. To put this model to work, we employ a staff of seasoned professionals, who can adapt to the ever-changing landscape of the pharmaceutical and medical device industries to analyze and identify barriers, and in turn, provide strategic advice that is actionable and feasible for our clients.

Our staff, on average, has 20+ years of senior-level professional expertise with experience in successful global integration, and all have advanced degrees (MD, Ph.D., PharmD, and MBA).

Q. What does innovation mean to Heim Global Consulting?

Innovation to HGC is to remain mentally dynamic in identifying barriers and constructing solutions. Following the status quo (I.e., “This is how it’s always been done”) is a detriment to any idea that could harbor greater efficiency, greater progress, and a greater product. Our clients benefit from a team of multidisciplinary consultants who can examine their problems from varying viewpoints.

Q. How does Heim Global Consulting foster a culture of innovation in the company?

HGC fosters a culture of innovation by encouraging our consultants to abandon a “one size fits all approach.” Through this abandonment, our consultants can provide strategic plans personalized to our client’s needs, ensuring that our clients receive the highest quality product upon delivery. We specialize in three sectors: venture capital, non-profit and pharmaceutical. We bring innovation to the market by identifying intersections and common needs across a robust breadth of expertise.

Q. Would you like us to highlight something important happening in your company that we may have missed asking?

We launched with a complete portfolio of services to be offered. Where we are seeing our biggest growth is in the advisory to VC and early-stage biotech companies. We have been able to secure Master Service Agreements (MSA) with large pharma, so now is the time to expand our footprint in those organizations. MSAs are complex to attain, so we are humbled by the outpouring of support in the first year of our company launch.

Additionally, earlier this year, we were named one of 2022’s 50 Smartest Companies of the Year by The Silicon Review, which is a tremendous honor.

Helping transform the global pharmaceutical and medical devices industry

Meg Heim is the Founder and President of Heim Global Consulting. She has a strong leadership background in Medical Affairs, External and Public Affairs, Operations, and Innovative Delivery systems, as well as extensive domestic & international experience in Pharmaceutical, Medical Device, and Health technology markets. A versatile leader, she has a reputation and consistent record of innovation for successful partnerships with Global and Domestic Corporate, Pharmaceutical, Biotech, Government, Advocacy, and Academic groups to create consensus and build programs that create healthcare transformative change. She is a results-oriented strategic thinker who deftly bridges from strategy to implementation, utilizing her superior motivational & communication skills to build and lead top-tier global and domestic teams to achieve goals.

Before founding Heim Global Consulting, Meg had a successful tenure at Sanofi Pharmaceuticals, where she held three roles of increasing responsibility, scope, impact, and oversight for all companies, including research and development throughout 110 countries. A critical member of the Chief Medical Office, as Global Head, Strategic Scientific Engagement Strategy, Operations, and Program Management, Meg was responsible for management oversight of Global Business Unit Strategic Scientific Stakeholder Engagement, R&D, Medical CRM, and companywide Event and Congress multinational strategy. Meg also led teams that were recognized as leaders in transformation, innovation, and technology.

Before Sanofi, as Worldwide Lead, Advocacy Cardiovascular, Diabetes, Immunoscience, and Rare Genetic Diseases at Bristol Myers-Squibb, Meg facilitated BMS being recognized in three national awards related to their advocacy and research work.

Meg currently sits on the Board of Directors of Healios AG Corporation, based in Basel Switzerland with offices in the US and Spain. Healios AG is a digital MedTech company that has worked with pharmaceutical companies and academic research teams in the EU and US to develop and validate digital biomarkers since 2014.

Meg received her MAS/BS from Fairleigh Dickinson College and maintains an active Registered Nurse License in New Jersey.

“Advisory for biotech, medical affairs, external affairs, and medical devices.”